Healthcare provider profile · identity verified

Caroline Humbles

Nurse Practitioner · AURORA, CO · NPI 1922462654

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	65
Lisinopril	Lisinopril	285	39
Amlodipine Besylate	Amlodipine Besylate	185	29
Gabapentin	Gabapentin	181	27
Metoprolol Succinate	Metoprolol Succinate	173	27
Furosemide	Furosemide	156	25
Trazodone Hcl	Trazodone Hcl	142	21
Eliquis	Apixaban	140	24
Levothyroxine Sodium	Levothyroxine Sodium	140	20
Alendronate Sodium	Alendronate Sodium	134	19
Losartan Potassium	Losartan Potassium	132	19
Pantoprazole Sodium	Pantoprazole Sodium	101	22
Duloxetine Hcl	Duloxetine Hcl	96	17
Metformin Hcl	Metformin Hcl	96	14
Carvedilol	Carvedilol	93	14
Rosuvastatin Calcium	Rosuvastatin Calcium	92	17
Venlafaxine Hcl Er	Venlafaxine Hcl	90	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	88	15
Omeprazole	Omeprazole	85	15
Escitalopram Oxalate	Escitalopram Oxalate	81	11
Hydralazine Hcl	Hydralazine Hcl	75	11
Pravastatin Sodium	Pravastatin Sodium	72	11
Hydrochlorothiazide	Hydrochlorothiazide	63	suppressed
Clopidogrel	Clopidogrel Bisulfate	62	suppressed
Finasteride	Finasteride	60	suppressed
Potassium Chloride	Potassium Chloride	59	15
Famotidine	Famotidine	58	14
Metoprolol Tartrate	Metoprolol Tartrate	58	11
Ezetimibe	Ezetimibe	56	suppressed
Chlorthalidone	Chlorthalidone	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	54	28
Lidocaine	Lidocaine	51	11
Sertraline Hcl	Sertraline Hcl	51	suppressed
Jardiance	Empagliflozin	50	suppressed
Tiotropium Bromide	Tiotropium Bromide	46	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	14
Xarelto	Rivaroxaban	45	suppressed
Mirtazapine	Mirtazapine	44	suppressed
Aripiprazole	Aripiprazole	43	suppressed
Gemtesa	Vibegron	43	suppressed
Latanoprost	Latanoprost	42	suppressed
Spironolactone	Spironolactone	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	14
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	38	suppressed
Levetiracetam	Levetiracetam	37	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Glipizide	Glipizide	32	suppressed
Mirabegron Er	Mirabegron	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	14
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Baclofen	Baclofen	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Dapagliflozin	Dapagliflozin Propanediol	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Cephalexin	Cephalexin	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	13
Prednisolone Acetate	Prednisolone Acetate	25	17
Tradjenta	Linagliptin	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	17
Methocarbamol	Methocarbamol	23	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Ozempic	Semaglutide	21	suppressed
Naltrexone Hcl	Naltrexone Hcl	20	suppressed
Benztropine Mesylate	Benztropine Mesylate	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Lurasidone Hcl	Lurasidone Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Hydroxyurea	Hydroxyurea	18	suppressed
Risperidone	Risperidone	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ofloxacin	Ofloxacin	15	11
Oxcarbazepine	Oxcarbazepine	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Digoxin	Digoxin	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Prednisone	Prednisone	13	suppressed
Prolia	Denosumab	13	11
Ramelteon	Ramelteon	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Torsemide	Torsemide	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error